Teladoc Health Statistics Share Statistics Teladoc Health has 176.69M
shares outstanding. The number of shares has increased by 2.46%
in one year.
Shares Outstanding 176.69M Shares Change (YoY) 2.46% Shares Change (QoQ) 1.02% Owned by Institutions (%) 71.98% Shares Floating 174.74M Failed to Deliver (FTD) Shares 77,888 FTD / Avg. Volume 1.09%
Short Selling Information The latest short interest is 23.62M, so 13.37% of the outstanding
shares have been sold short.
Short Interest 23.62M Short % of Shares Out 13.37% Short % of Float 14.95% Short Ratio (days to cover) 3.37
Valuation Ratios The PE ratio is -1.55 and the forward
PE ratio is -9.71.
Teladoc Health's PEG ratio is
0.
PE Ratio -1.55 Forward PE -9.71 PS Ratio 0.6 Forward PS 0.5 PB Ratio 1.04 P/FCF Ratio 5.48 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Teladoc Health.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.77,
with a Debt / Equity ratio of 1.06.
Current Ratio 1.77 Quick Ratio 1.73 Debt / Equity 1.06 Debt / EBITDA -2.7 Debt / FCF 5.6 Interest Coverage -42.89
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $556.18K Profits Per Employee $-216.72K Employee Count 4,620 Asset Turnover 0.73 Inventory Turnover 19.7
Taxes Income Tax 7.59M Effective Tax Rate -0.76%
Stock Price Statistics The stock price has increased by -0.39% in the
last 52 weeks. The beta is 1.85, so Teladoc Health's
price volatility has been higher than the market average.
Beta 1.85 52-Week Price Change -0.39% 50-Day Moving Average 7.78 200-Day Moving Average 8.69 Relative Strength Index (RSI) 51.45 Average Volume (20 Days) 7,178,496
Income Statement In the last 12 months, Teladoc Health had revenue of 2.57B
and earned -1B
in profits. Earnings per share was -5.87.
Revenue 2.57B Gross Profit 1.82B Operating Income -1.02B Net Income -1B EBITDA -587.01M EBIT -969.85M Earnings Per Share (EPS) -5.87
Full Income Statement Balance Sheet The company has 1.3B in cash and 1.58B in
debt, giving a net cash position of -286.29M.
Cash & Cash Equivalents 1.3B Total Debt 1.58B Net Cash -286.29M Retained Earnings -16.23B Total Assets 2.89B Working Capital 671.5M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 293.68M
and capital expenditures -10.79M, giving a free cash flow of 282.89M.
Operating Cash Flow 293.68M Capital Expenditures -10.79M Free Cash Flow 282.89M FCF Per Share 1.66
Full Cash Flow Statement Margins Gross margin is 70.76%, with operating and profit margins of -39.73% and -38.97%.
Gross Margin 70.76% Operating Margin -39.73% Pretax Margin -38.67% Profit Margin -38.97% EBITDA Margin -22.84% EBIT Margin -39.73% FCF Margin 11.01%
